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INTRODUCTION
Human  cytomegalovirus  (HCMV)  is  a  member 
of  the  Betaherpesviridae  family  and  subfamily 
Betaherpesvirinae  that  establishes  a  life-long  per-
sistent  infection  (Huang  and  Kowalik,  1993).  In 
immunocompromised patients, such as individuals 
with AIDS and patients taking immunosuppressive 
drugs following transplantation, HCMV may cause 
severe disease (Britt and Alford, 1996). This virus is 
a cause of the most important congenital infection 
and may lead to developmental damage of the cen-
tral nervous system including hearing loss, mental 
retardation,  and  visual  impairment  (Alford  et  al., 
1990).
Protease-activated receptors (PAR) 1, 3, and 4 
are responsible for the cellular response to throm-
bin,  the  key  effector  protease  of  the  coagulation 
cascade (Coughlin, 2005). These receptors belong 
to a family of 7-transmembrane G protein-linked 
receptors  proteolytically  and  irreversibly  activated 
by thrombin (Brass et al., 1994; Hein et al., 1994). 
Described  as  the  prototypical  thrombin  receptor, 
PAR-1 is rapidly desensitized after activation, fol-
lowed by internalization and trafficking in the lyso-
somes. Recovery of thrombin responsiveness is due 
to replenishment of the cell surface with new recep-
tors (Hein et al., 1994). The presence of a protected 
intracellular PAR-1 pool in many cell types (such as 
ECs, smooth muscle cells, and fibroblasts) with at 
least as many receptors as are present initially on the 
cell surface provides a mechanism for quick recov-
ery after activation, independent of protein synthe-
sis (Woolkalis et al., 1995; Ellis et al., 1999). In the 
absence of an agonist, PAR-1 cycles at very low rates 
between the cell surface and the intracellular pool 
(Shapiro et al., 1996; Shapiro and Coughlin, 1998) 
and the time required for new PAR-1 synthesis after 
cleavage by thrombin is 24 hours (Yan et al., 1996).
The regulatory region of the human thrombin 
receptor gene has been cloned, and DNA sequence 
analysis indicates the presence of many regulatory 
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factor-binding  elements,  including  two  AP-2/Sp1 
complexes in the proximal 3’ region of the promoter. 
Overall, these complexes contain four putative AP-
2-binding elements (Tellez and Bar-Eli, 2003) and 
seven  Sp1-binding  elements  (Wu  et  al.,  1998)  as 
shown in Fig. 1. The regulatory region of the throm-
bin receptor gene shares remarkable similarities with 
some other AP-2 target genes, such as a GC-rich 
sequence, lack of conventional TATA sequences, and 
multiple AP-2-binding elements (Tellez et al., 2003; 
Tellez and Bar-Eli, 2003).
Here  we  sought  to  determine  the  minimal 
HCMV-responsive  element  within  the  PAR1  pro-
moter  and  investigate  if  promoter  activity  could 
be  mediated  by  NF-κB  transcription  machinery 
(Ghosh et al., 1998), in particular p52/RelB, upon 
HCMV exposure. 
MATERIAL AND METHODS
Cell isolation and culture
Human umbilical vein endothelial cells (HUVEC) 
were isolated and maintained as previously described 
(Laumonnier  et  al.,  2000).  In  all  experiments, 
HUVEC were used between passages 2 and 6.
Virus culture and determination of virus titer
Human cytomegalovirus, laboratory strain AD-169 
(HCMV-AD169), was purchased from ATCC and 
propagated in MRC-5 cells. A confluent monolayer 
of  MRC-5  cells  was  inoculated  with  virus  [0.01 
cytopathic  effects  (CPE)  per  cell]  in  serum-free 
medium. Cells were washed after 90 min and further 
cultured in growth medium until cytopathic effects 
were  apparent  in  approximately  100%  of  cells. 
Infected cells were then replenished by fresh culture 
medium. After 5 days, the supernatant containing 
viral  particles  was  collected  and  centrifuged  at 
1000x  rcf  at  4°C  for  15  min.  To  sediment  virus 
particles, debris-free supernatant was then subjected 
to ultracentrifugation at 20000 rcf at 4°C for 1 h. The 
supernatant was carefully discarded and the virus 
pellet  resuspended  in  500  µl  of  growth  medium, 
aliquoted, and stored at -80°C for further use. For 
each independent experiment, fresh aliquots from 
the same preparation were used.
The virus titer was determined by virus plaque 
assay. Virus samples were serially diluted in serum-
free medium and adsorbed to MRC-5 cells plated 
in 24-well plates at a density of 105 cells per well. 
Inoculum was replaced with culture medium after 
90 min. After 10 days, the cells were stained with 
Giemsa solution. White plaques were counted and 
the  virus  titer  was  presented  as  the  number  of 
cytopathic  effects  (CPE)  per  volume  of  infected 
medium, also known as the multiplicity of infection 
(MOI).
PAR1 promoter deletions and expression plasmids
We  made  PAR1  promoter  deletions  by  PCR 
amplification  using  the  Advantage  GC  Genomic 
PCR kit having GC melt in order to break strong 
guanine-cytosine  bonds  in  the  genomic  DNA. 
Primers were designed to carry restriction sites for 
SacI  and  XhoI  restriction  enzymes,  providing  so-
called “sticky ends”. Further, constructs were cloned 
into the pGL-3Enhancer luciferase reporter vector 
(Promega  GmbH,  Mannheim,  Germany)  in  the 
multiple cloning region between the aforementioned 
restriction sites. Primer sequences of constructs and 
PCR condition are given in Table 1.
The  p52  and  RelB  expression  plasmids  were 
kindly  provided  by  the  Papillomavirus  Research 
Unit, University of Quensland, Australia. Expression 
plasmids  were  cloned  into  the  EcoRV  and  NotI 
restriction  sites  of  the  pcDNA3  vector  (Promega 
GmbH, Mannheim, Germany).
Fig. 1. Putative transcriptional regulatory sequences of the PAR1 gene (Tellez, C., Oncogene 2003; 22: 3130-3137).THE P52/RELB MODULATE ACTIVITY OF PAR1 REPORTER GENE 615
Gene reporter assay
The HUVEC used were either mock- or HCMV-
exposed (MOI 5) in serum-free medium for 1 h, 
washed, and transiently transfected with PAR1 pGL-
3Enhancer luciferase reporter  constructs containing 
full-length  and  progressively  shorter  promoter 
sequences of the human PAR1 gene alone or together 
with  p52  +  RelB  (p52/RelB)  expression  plasmids 
using the SuperFect transfection reagent according 
to  instructions  provided  by  the  manufacturer 
(Quiagen  GmbH,  Hilden,  Germany).  After  48  h, 
cells  were  harvested  and  lyzates  were  assayed  for 
luciferase  activity  using  the  Luciferase  Reporter 
Assay System kit (Promega, Madison, WI, USA) in 
a plate luminometer (Stratec Biomedicine Systems 
AG,  Birkenfeld,  Germany).  We  used  HUVEC 
tansfected  with  a  vector  containing  the  luciferase 
gene  to  control  non-specific  viral  effects.  Results 
were normalized to the luciferase activity in mock-
transfected HUVEC.
Statistical analysis
Values  shown  represent  means  ±  SEM.  Statistical 
significances  were  calculated  with  the  Newman-
Keuls test for multi-group comparisons.
RESULTS
Human cytomegalovirus significantly increases
activity of PAR1 reporter deletion constructs
The  regulatory  region  of  the  human  thrombin 
receptor  gene  has  been  cloned.  Analysis  of  DNA 
sequences indicates the presence of many transcrip-
tion factor-binding elements, including 2 AP-2/Sp1 
complexes in the proximal 3´ region of the promoter 
(Schmidt et al., 1996; Wu et al., 1998; Tellez and 
Bar-Eli, 2003). In HUVEC, basal activities of trans-
fected reporter constructs did not differ significantly 
when compared to the full-length PAR-1106 con-
struct, though activity of the shortest one, PAR1-87, 
was approximately 30% lower compared to PAR1-
1106 (Fig. 2). However, the virus did significantly 
induce activity of all constructs as compared to their 
respective basal activities with the exception of the 
PAR1-87 construct. Moreover, activity of PAR1-863 
was  significantly  higher  compared  to  PAR1-1106, 
suggesting the presence of a DNA sequence in the 
full-length  promoter  that  interferes  with  HCMV 
activation of the PAR1 promoter. 
Human cytomegalovirus activates the PAR1
promoter via p52/RelB
To  investigate  if  p52/RelB  transcription  factors 
Table 1. Summary of PAR1 promoter deletion constructs. Deletion constructs were generated by PCR amplification. Reaction 
conditions were as follows: initial denaturation at 94oC for 5 min, 35 cycles of denaturation at 94oC for 30 sec, annealing at 64oC 
for 30 sec, and elongation at 72oC for 90 sec. All PCR reactions were run on GeneAmp PCR System 2400 PE and GeneAmp PCR 
System 9700.
Construct 5’ primer 3’ primer
PAR1-1106 (1,2kb) ATGCGAGCTCCCAGTGGCAA
AGCAACTT
ATTACTCGAGCCTCCGGCGT
GCAGTGAGAGTCTCTGC
PAR1-863 (957bp) ATGCGAGCTCTTCTGTGGTC 
CCAGGTAATCCG
ATTACTCGAGCCTCCGGCGT
GCAGTGAGAGTCTCTGC
PAR1-526 
(620bp)
AGCTGAGCTCGCCGCTCTTC 
CTATTCCACTCGCA
ATTACTCGAGCCTCCGGCGT
GCAGTGAGAGTCTCTGC
PAR1-298 (392bp) GATCGAGCTCACTGAACTTT 
GCCGGTGTCCCA
ATTACTCGAGCCTCCGGCGT
GCAGTGAGAGTCTCTGC
PAR1-87 (181bp) ACTAGAGCTCCGAATCAACG 
GTGCCCAGAGGA
ATTACTCGAGCCTCCGGCGT
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could mediate PAR1 reporter activation, mock- or 
HCMV-exposed  HUVEC  were  transiently  trans-
fected with either the PAR1 reporter gene alone or 
together with p52/RelB. As shown in Fig. 3, trans-
fection of p52/RelB increased basal activity of the 
PAR1 reporter gene threefold, but not significantly. 
However, in virus-inoculated cells, promoter activ-
ity was significantly over-activated upon p52/RelB 
transfection  compared  to  either  p52/RelB  trans-
fected- or HCMV-inoculated cells.
DISCUSSION
In the present study, we showed that exposure to 
HCMV significantly increases activity of all PAR1 
deletion constructs (Schmidt et al., 1996), with the 
exception of the shortest one, PAR1-87, when com-
pared to their basal activities. Progressively shorter 
fragments carrying none of the AP-2-like binding 
elements (Schmidt et al., 1996) had markedly lower 
activities upon virus exposure when compared to 
Fig. 2. Human cytomegalovirus increases activity of PAR1 reporter constructs. Gene reporter assay: HUVEC, HMCV-(5 MOI) or 
mock-infected, were transfected with vectors encoding PAR1 reporter gene constructs. Cells were analyzed for luciferase activity 
after 48 h. Data were normalized to total protein concentration and presented as MEANS ± SEM of n = 6 independent experiments. 
ns – not significant, *p < 0.05, **p < 001, ***p < 0.0001.
Fig. 3. The p52/RelB expression plasmids significantly increase PAR1 reporter activity in HCMV-exposed HUVEC. Gene reporter 
assay: HUVEC, HMCV-(5 MOI) or mock-infected, were transfected with vectors encoding either the PAR1 reporter gene alone or 
together with p52/RelB plasmids. Cells were analyzed for luciferase activity after 48 h. Data were normalized to total protein concen-
tration and presented as MEANS ± SEM of independent experiments: n = 14 for the PAR1 promoter and n = 8 for p52/RelB. ns – not 
significant, *p < 0.05, **p <.001, ***p < 0.0001.THE P52/RELB MODULATE ACTIVITY OF PAR1 REPORTER GENE 617
either PAR1-1106 or PAR1-863 constructs. This sug-
gests an important (but not crucial) role for AP-2-
like binding elements, since their activities in virus-
exposed cells were still markedly higher than their 
corresponding basal activities. Interestingly, activity 
of PAR1-863 was higher than that of PAR1-1106, 
suggesting the presence of potentially inhibitory fac-
tors in the full-length promoter. Furthermore, anal-
ysis of PAR1-526-carrying complexes 1 (3 AP-2/5 
Sp1) and 2 (1 AP-2/2 Sp1) and PAR1-298 carrying 
only complex 2 revealed comparable levels of activ-
ity upon virus exposure, but still significantly higher 
when compared to their basal activities, suggesting 
an important role for complex 2. Moreover, activity 
of the PAR1-87 construct, carrying none of the regu-
latory binding elements and none of the complexes, 
was only marginally increased when exposed to the 
virus, and its basal activity was approximately 30% 
lower than activity of PAR1-1106, pointing to a cru-
cial role for complex 2 (Wu et al., 1998; Tellez and 
Bar-Eli, 2003). 
Taking all the data into account, we anticipated a 
crucial role for AP-2/Sp1 regulatory elements in con-
cert with p52/RelB (Ghosh et al., 1998). However, it 
remains to be elucidated whether p52/RelB mediate 
PAR1 promoter activation directly or indirectly by 
influencing AP-2/Sp1 regulatory elements to bind to 
their corresponding binding sites within the PAR1 
promoter.
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У HUVEC, ТРАНСКРИПЦИОНИ ФАКТОРИ P52/RElB ПОСРЕДУЈУ У АКТИВАЦИЈИ 
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Аутори су у овој студији анализирали утицај 
HCMV (AD-169) на регулацију активности PAR1 
промотора у HUVEC. У овим ћелијама, излага-
ње вирусу је значајно повећало активност PAR1 
репортер  конструката  који  носе  AP-2-сличне 
везујуће елементе заједно са AP-2/Sp1-везујућим 
елементима  организованим  у  два  комплекса. 
Активност прогресивно краћих конструкти који 
немају  AP-2-сличне  везујуће  елементе  је  била 
знатно  смањена  после  излагања  вирусу,  али  и 
даље значајно већа од њихових основних актив-
ности  измерених у ћелијама које нису биле у 
додиру са вирусом. Међутим, активност најкра-
ћег конструкта, који не поседује нити један везу-
јући елемент, није била значајно повећана у ћели-
јама изложеним вирусу нити је активност била 
значајно  повећана  у  односу  на  основну  актив-
ност самог конструкта. Аутори су још показали 
да у ћелијама изложеним вирусу, транскрипцио-
ни фактори p52/RelB значајно повећавају актив-
ност PAR1 репортера. Аутори на крају дискусије 
закључују  да  је  активност  PAR1  промотора  у 
великој  мери  зависна  од  присуства  AP-2/Sp1-
везујућих елемената, али и да транскрипциони 
фактори p52/RelB значајно регулишу активност 
промотора у ћелијама изложеним вирусу.